Lantheus

PYLARIFY

Manufacturer:

Lantheus

Pylarify HCPCS:

A9595

HCPCS Code Descriptor:

Piflufolastat f-18, diagnostic, 1 millicurie

Category:

A Code

Pylarify NDCs:

71258-0022-00

Primary Type:

Imaging/Radiopharmaceutical

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

71258-0022-00

About Pylarify:

PYLARIFY is an Imaging/Radiopharmaceutical drug manufactured by Lantheus and administered via the Intravenous route of administration. The A Code: A9595 is aligned to the drug PYLARIFY.

ACCESS PRICING AND MORE BY REGISTERING

A9595 Added Date:

January 1, 2022

A9595 Effective Date:

January 1, 2022

A9595 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Pylarify billing and coding information.
Our team did not identify a source for Pylarify patient assistance information. Please reach out to our team if you feel that this is a mistake.
PYLARIFY prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for PYLARIFY. Please check back in a few weeks.